CARGO CONNECTION LOGISTICS HOLDING (OTCBB: CRGO)
"Up 200.00% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/CRGO.php

Cargo Connection Logistics Holding, Inc., through its subsidiaries, provides logistics solutions in North America. It primarily provides truckload and less-than-truckload transportation services, as well as provides value-added logistics services, including provision of the U.S. Customs Bonded warehouse facilities and container freight station operations. The company also provides pick and pack services comprising changing labels or tickets on items, inspection of goods into the United States, and recovery of goods damaged in transit. Cargo Connection Logistics Holding is based in Inwood, New York.

CRGO News:

February 2 - ValuEngine Industry Report Pertaining to Cargo Connection Logistics Holding Released

A ValuEngine Industry Report pertaining to Cargo Connection Logistics Holding, Inc. (OTCBB: CRGO) has been released. Visit http://bit.ly/9rgOdW for more information.

SAVI MEDIA GROUP INCORPORATED (OTC: SVMI)
"Up 130.00% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/SVMI.php

SaVi Automotive, Inc., a division of Savi Media Group, creates and commercializes the world’s best blow-by gas and crankcase engine emission reduction technology. We have created the World’s first truly simple gasoline and diesel engine emission reduction technology and it allows us to provide our clients a lower-cost and more effective and efficient emission reduction and engine efficiency (leading to better mileage and lifespan) solutions.

SVMI News:

February 2 - Recent Vehicle Testing Results for Fleet Markets

SaVi Media Group (OTC: SVMI) announces recent vehicle testing results for Fleet Markets, a core marketing/sales strategy for 2010. The seven vehicle types were tested both prior to DynoValve installation and after installation, showing significant improvement in both engine performance and emissions reduction. In addition, vehicles also demonstrated increased fuel mileage.

The Chevy 30 Step Van, a mainstay of the Corporate/ Business Fleet market resulted in consistent 60% increases in fuel mileage through multiple tests. Impala and Crown Victoria, stalwarts for Municipal/State Fleet market, showed 20-25% improvement in fuel mileage testing.

The Specialty Fleet Market testing concentrated on car clubs and limousines. Hummer Limo, Hummer, Ford pick-ups, Motor home and other vehicles were tested and had increased fuel mileage depending on the vehicle.

Multiple tests were conducted and measured on each vehicle for 100 miles of highway driving on each test. To view the test results, visit www.saviautomotive.com/test-results.doc.

"We are very pleased with our recent DynoValve testing results. The results will greatly assist and support the efforts by our sales and marketing teams as we move forward concentrating on Corporate, Business, Municipal and Specialty Fleet markets throughout the country in 2010," stated Serge Monros, Chief Executive Officer of SaVi Media Group, Inc.

In other news, Savi Media Group will be announcing the launch of a new corporate website near the end of March supporting our distributors for our products and shareholders alike.

CYBERLUX CORPORATION (OTCBB: CYBL)
"Up 100.00% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/CYBL.php

Cyberlux Corporation, a leader in solid-state lighting innovation, has developed breakthrough LED lighting technology that provides the most energy efficient and cost effective portable lighting solutions available today for military and commercial uses. The Military and Homeland Security products provide tactical covert and visible lighting capability and are designed as highly mobile, battery-powered lighting systems ideal for threat detection, force and asset protection and general expeditionary lighting needs.

CYBL News:

February 3 - Cyberlux Corporation Files Patents for Exclusive Products Contracted by New OEM Customers

Company Patents Intellectual Property Developed for New OEM Products

Cyberlux Corporation (OTCBB: CYBL), a leading provider of LED lighting solutions, announced today that the Company has recently filed for patent protection for four new products developed for its new OEM customers. The Company’s new patent filings address the apparatus and methods for providing unique solid-state lighting technology encompassed in four product solutions, extending the existing Cyberlux patent portfolio for future product development. The Cyberlux OEM clientele have received orders and contracts from both governmental agencies, as well as large, multi-national retailers for the products designed by Cyberlux.

Encompassed in two new patent filings, the Cyberlux Portable Shelter Lighting (PSL) and Enclosed Shelter Lighting (ESL) systems deliver the most energy efficient white and red LED lighting available in a fixed or portable lighting solution for enclosed spaces. Designed to provide ideal light dispersion and illumination for the portable shelter and “command and control” environments, Cyberlux engineered the PSL and ESL system configurations to flexibly illuminate environments of any size and scale, all powered by either AC or DC power, including DC solar power. Meeting the requirements of the world class, multi-national OEM customer, who provides specialized command and control systems to all branches of the U.S. and foreign military services, homeland defense and first responders, the PSL and ESL products expand the Cyberlux OEM product offerings to the Department of Defense (DoD) supplier marketplace and address the significant fluorescent lighting technology transition.

The Cyberlux I-Safe LED Lighting products are designed to meet the stringent Intrinsically Safe certification standards required to safely operate lighting products in hazardous, flammable environments, such as First Responders are typically required to do. Encompassed in two additional patent filings, the Cyberlux I-Safe products are engineered to contain no components or circuits that hold enough electrical energy or thermal energy to cause an ignition to occur. The Cyberlux I-Safe LED Lighting products provide multi-mode task and work lighting in compact, light-weight designs that are flexible and adaptable and made from chemical and corrosive resistant materials. Utilizing unique Cyberlux LED technology that produces 50 – 120 lumens from AAA, C, D to 6V battery power, the Cyberlux I-Safe LED Lighting products operate for 20 – 60 hours, are waterproof, are impact resistant from a 2 meter drop and meets the Intrinsically Safe standards of multiple agencies, including the Mine Safety and Heath Association (MSHA) standards. As part of the Cyberlux / Spectrum Brands Supplier Agreement, Cyberlux will exclusively supply Spectrum Brands with the proprietary I-Safe LED Lighting products which Spectrum Brands will evaluate for distribution to their global retail and commercial client base.

“Cyberlux is excited to have already received orders and contracts for the LED solutions designed for our military clients, as well as for our large retail client. The Company’s expanding patent claims portfolio will not only provide patent protection for our important LED products and lighting systems, but will also provide an ongoing development platform for future products,” said Mark Schmidt, president and chief executive officer for Cyberlux. “The Company’s ability to partner with significant OEM customers, develop, patent and produce innovative solid-state lighting products is strategically important and supports our focus on near-term profitability and long-term growth.”

With proprietary Cyberlux LED technology, unique product knowledge and OEM production capability, Cyberlux is positioned to be a leading LED solution provider for both new and existing OEM customers.

HOME DIAGNOSTICS INCORPORATED (NASDAQ: HDIX)
"Up 89.26% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/HDIX.php

Based in Fort Lauderdale, Florida, Home Diagnostics is a leading developer, manufacturer and marketer of diabetes management products. Home Diagnostics offers a portfolio of high-quality blood glucose monitoring systems that spans the spectrum of features and benefits to help every person with diabetes better monitor and manage their disease. The Home Diagnostics product line includes TRUE2go™, TRUEresult®, TRUEtrack®, TRUEbalance™, Sidekick®, TRUEread® and Prestige IQ® blood glucose monitoring systems. The products are available in more than 45,000 pharmacies throughout the U.S. Home Diagnostics is the exclusive co-brand supplier of blood glucose monitoring systems for leading pharmacies including CVS, Rite Aid and Walgreens, as well as distributors such as AmerisourceBergen, Cardinal Health, McKesson, Invacare and Liberty Medical. Home Diagnostics was named one of Forbes magazine’s “200 Best Small Companies” in 2008, and in 2009 received several recognitions for the company’s TRUE2go blood glucose meter, including a Medical Design Excellence Award (MDEA) and a Gold Award in the Medical/Test Equipment category as part of appliance DESIGN Magazine’s 22nd Annual Excellence in Design (EID) Awards Competition.

HDIX News:

February 3 - Home Diagnostics, Inc. Agrees to Be Acquired by Nipro Corporation; Companies Sign Definitive Agreement

Nipro Corporation to Commence All-Cash Tender Offer at $11.50 per share for 100% of Home Diagnostics’ Outstanding Shares

Home Diagnostics, Inc. (Nasdaq: HDIX), a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics’ common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million). The offer price represents an approximately 90% premium to the closing price of Home Diagnostics’ common stock on February 2, 2010, and an approximately 83% premium to Home Diagnostics’ average closing price for the preceding 90 days.

The two-step acquisition will be effected by means of a first-step, cash tender offer commenced by a wholly-owned subsidiary of Nipro for all of the outstanding shares of Home Diagnostics’ common stock, at $11.50 net per share in cash, followed by a second-step merger in which untendered Home Diagnostics’ shares will be acquired at the same $ 11.50 net cash price per share. All Home Diagnostics’ stock options and stock appreciation rights will receive cash equal to the excess, if any, of $11.50 over their exercise price.

The transaction has been approved by Nipro and the board of directors of Home Diagnostics. The tender offer, which will remain open for a minimum of 20 business days, subject to certain extensions as required by applicable law and the terms of the merger agreement, is subject to certain conditions, including the valid tender and acceptance for payment in the tender offer of a majority of the fully diluted Home Diagnostics common stock, the expiration or early termination of the applicable waiting period under the Hart-Scott-Rodino Act, and other customary conditions. The tender offer is not subject to a financing condition.

Certain stockholders of Home Diagnostics, owning in the aggregate approximately 15% of Home Diagnostics’ outstanding common stock, have committed to tender their shares in the offer. Home Diagnostics has also granted Nipro a “top-up” option exercisable under certain circumstances to enable Nipro to own 90% of the fully diluted Home Diagnostics common stock and complete the second step of its acquisition of Home Diagnostics by means of a “short form” merger not requiring approval by Home Diagnostics’ stockholders. Nipro has also reserved the right to commence a “subsequent offering period” following the expiration of the initial tender offer period if Nipro then owns less than 90% of the fully diluted Home Diagnostics common stock.

The merger agreement permits Home Diagnostics’ board, under certain circumstances prior to the completion of the Offer, to enter into discussions and negotiations and furnish information to third parties who submit to Home Diagnostics unsolicited acquisition proposals which Home Diagnostics’ board of directors determines to be reasonably likely to lead to a superior offer and, thereafter, to terminate the transaction with Nipro and enter into a definitive agreement providing for a superior offer, subject to Nipro’s right to match or improve the terms of any such superior offer and further subject to the payment to Nipro of a $6,500,000 termination fee or reimbursement of certain of Nipro’s out of pocket expenses in other circumstances.

Joseph Capper, President and CEO of Home Diagnostics, said, “First and foremost, we are pleased to announce this transaction which provides a substantial current cash premium to our stockholders. We believe this transaction is also beneficial to our customers and suppliers because it greatly enhances Home Diagnostics’ capabilities by expanding our product offering and aligning our business with a global healthcare company.”

The parties expect the tender offer to commence on or about February 10, 2010. The tender offer will remain open for 20 business days from commencement, subject to extension under certain circumstances as required by applicable law and the terms of the merger agreement. Subject to the satisfaction of the conditions to the tender offer, the offer is expected to be consummated prior to the end of the first quarter of 2010.

With respect to the transactions, Raymond James Financial, Inc. is acting as financial advisor to Home Diagnostics; Satterlee Stephens Burke & Burke LLP is acting as legal advisor to Home Diagnostics; and Greenberg Traurig, LLP is acting as special M&A counsel to Home Diagnostics. Baker & McKenzie LLP is acting as legal advisor to Nipro Corporation.

ABOUT NIPRO CORPORATION

Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), founded in 1954, is engaged directly and through its subsidiaries principally in the development, manufacture and sale of medical devices, pharmaceutical products and medical and glass products. Nipro’s medical device division is engaged in the manufacture and sale of medical devices and its related products, the development, manufacture and sale of cell culturing-related products, as well as the development and sale of diabetes-relates products. Nipro’s pharmaceutical division is engaged in the research, manufacture and sale of pharmaceuticals, such as blood derivatives. The instrument division of Nipro manufactures and sells glass pipes and other glass products, including the inner bottles of thermos bottles. Nipro and its subsidiaries also sell medical device manufacturing equipment and conduct real estate leasing and non-life insurance agency businesses.

HY'BRED INTERNATIONAL INCORPORATED (OTC: HYII)
"Up 84.62% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/HYII.php

The Hy'Bred horseshoe is the most advanced Aluminum/Urethane horseshoe on the market today. Unsurpassed shock absorption, superior traction and improved protection, combined with the best wear resistance of any synthetic horseshoe makes the Hy'Bred the ultimate choice for every horse.

HYII News:

January 26 - HY'BRED International, Inc. Expands Product Base for Multiple Revenue

Signs Letter of Intent for Exclusive Rights for Equine Products With Rollins Resources, Inc.

HY'BRED International, Inc. (OTC: HYII), a company which focuses on the equine wellness industry, announces that they have signed a letter of intent with Rollins Resources, Inc. to be the exclusive distributor of their equine product line in the United States. Rollins Resources, Inc. focuses on manufacturing rubber products such as mats, rubber spray-on surfaces, and most importantly, Equine surfacing flakes. The equine flakes are fragmented pieces of rubber that give race tracks more absorption of stress, taking pressure off the horses' legs. This technology is almost entirely dust free, which will provide the horses and riders more ease on their respiratory systems.

"We are excited to be working with Rollins Resources, Inc. As we expand HY'BRED International, Inc.'s product lines, we are only seeking products that meet HY'BRED's highest quality standards. The products that we will be distributing for Rollins Resources fit that category. Their products surpass all technology currently used and are developed as 'green technology.' This means they are produced from used rubber," explained HY'BRED C.E.O. Gary Kouletas. "With over $100 million dollars spent yearly in this sector of the equine industry, we feel we have a product that will definitely move HY'BRED to the forefront of the marketplace."

MARKETING CONCEPTS INTERNATIONAL (OTC: MCCI)
"Up 50.00% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/MCCI.php

Marketing Concepts International is positioned to work with smaller companies that we determine are likely to significantly benefit from the acquisition of working capital and professional business guidance. These client corporations will be at the earliest stage of their growth potential, and as such will provide the greatest opportunity for a substantial financial return for our services. The company’s corporate strategy is to provide business development services to smaller corporations and start-ups in exchange for a share of the client corporation's sales revenue. The services provided include: marketing consulting, management consulting, capital acquisition services, web site development, sales consulting, negotiating services, and partnership development.

MCCI News:

May 14 - Seakinetics Corporation Completes Its Intention to Acquire Controlling Interest in Marketing Concepts International Inc.

Marketing Concepts International Inc. (OTC: MCCI) (the "Company") and Seakinetics Corporation (Frankfurt: M90) announced that they have finalized the agreement affording Seakinetics Corporation a controlling interest in Marketing Concepts International. Seakinetics will participate in funding initiatives as required to provide additional working capital to Marketing Concepts. These funding infusions are expected to fuel substantial growth in revenues.

The Company's President and CEO, Kenneth W Mann confirmed that the final agreement provides for an exchange of treasury stock from each Company as follows: Seakinetics, which currently trades on the Frankfurt Exchange at roughly 1.75 Euro per share, will deposit into the Company's trust account 160,000 restricted shares of its stock with a current market value of USD $328,000 in exchange for a 37.5% interest in Marketing Concepts International. Seakinetics will retain a further option for an additional 15% of treasury stock issued under rule 144 at a discount of 10% to market.

Seakinetics will be appointing one board member to the Board of Directors of Marketing Concepts International within the next 60 days.

Seakinetics was established for the purpose of designing, developing, marketing and investing in innovative technologies and services in the renewable energy field. Seakinetics' mission is to be the best in finding solutions for renewable energy today and for the foreseeable future.